SCM
EW icon

Sterling Capital Management’s Edwards Lifesciences EW Stock Holding History

Sterling Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
17,290
+16,099
+1,352% +$1.35M 0.03% 414
2026
Q1 		$95.4K Hold
1,191
– – ﹤0.01% 1410
2025
Q4 		$102K Sell
1,191
-744
-38% -$61.1K ﹤0.01% 1523
2025
Q3 		$150K Buy
1,935
+9
+0.5% +$703 ﹤0.01% 1408
2025
Q2 		$151K Sell
1,926
-3,973
-67% -$296K ﹤0.01% 1300
2025
Q1 		$428K Sell
5,899
-351
-6% -$25.1K 0.01% 916
2024
Q4 		$463K Sell
6,250
-377
-6% -$26.4K 0.01% 954
2024
Q3 		$437K Buy
+6,627
New +$481K 0.01% 931
2018
Q4 		– Sell
-124,752
Closed -$7.24M – 869
2018
Q3 		$7.24M Hold
124,752
– – 0.07% 217
2018
Q2 		$6.05M Hold
124,752
– – 0.06% 224
2018
Q1 		$5.8M Buy
124,752
+6,618
+6% +$287K 0.05% 234
2017
Q4 		$4.44M Buy
118,134
+42,081
+55% +$1.54M 0.04% 267
2017
Q3 		$2.77M Buy
76,053
+4,413
+6% +$168K 0.03% 330
2017
Q2 		$2.82M Buy
71,640
+37,347
+109% +$1.36M 0.03% 312
2017
Q1 		$1.07M Buy
+34,293
New +$1.07M 0.01% 559
2016
Q1 		– Sell
-11,544
Closed -$304K – 933
2015
Q4 		$304K Sell
11,544
-27,744
-71% -$720K ﹤0.01% 865
2015
Q3 		$931K Buy
39,288
+10,842
+38% +$262K 0.01% 555
2015
Q2 		$675K Buy
28,446
+18,474
+185% +$417K 0.01% 538
2015
Q1 		$237K Buy
+9,972
New +$224K ﹤0.01% 822

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sterling Capital Management's EW Position: Q2 2026 in Review

Sterling Capital Management increased its Edwards Lifesciences (EW) stake by 1,352% in Q2 2026, buying an estimated $1.35M and bringing the position to 17,290 shares worth $1.56M. The position accounts for 0.03% of the portfolio, ranked #414.

Sterling Capital Management first reported a position in EW in Q1 2015 and has held it in 19 quarters since. The position peaked at $7.24M in Q3 2018. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sterling Capital Management held 17,290 shares of Edwards Lifesciences worth $1.56M as of Q2 2026.
  • Sterling Capital Management bought 16,099 Edwards Lifesciences shares in Q2 2026, an estimated $1.35M.
  • Edwards Lifesciences made up 0.03% of Sterling Capital Management's portfolio in Q2 2026, its #414 holding.
  • Sterling Capital Management first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 19 quarters since.
  • Sterling Capital Management's Edwards Lifesciences position peaked at $7.24M in Q3 2018.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.